Q2 2019 Supernus Pharmaceuticals Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Supernus Pharmaceuticals Second Quarter 2019 Financial Results Conference Call. (Operator Instructions) As a reminder, this call is being recorded.
I would now like to turn the call over to Peter Vozzo of Westwicke, Investor Relations for Supernus Pharmaceuticals. You may begin.
Thank you, Sara. Good morning, everyone, and thank you for joining us today for Supernus Pharmaceuticals' Second Quarter 2019 Financial Results Conference Call. Yesterday, after the close of the market, the company issued a press release announcing these results. On the call with me today are Supernus' Chief Executive Officer, Jack Khattar; and Chief Financial Officer, Greg Patrick. Following remarks by management, we will open the call to questions.
During the course of this call, management may make certain forward-looking statements regarding future events and the company's future performance. These forward-looking statements reflect Supernus' current perspective on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |